US Food and Drug Administration (FDA)
McKenna Tennant, MPH, is a Policy Analyst on the Personalized Medicine team in the Office of In Vitro Diagnostics (OHT7) within FDA's Center for Devices and Radiological Health (CDRH). In her current position, McKenna contributes to the development and implementation of in vitro diagnostic regulatory policy and procedures to assure that patients have access to safe, effective, and high-quality in vitro diagnostic devices. McKenna also supports OHT7's efforts to foster innovation and advance regulatory science for in vitro diagnostic devices for personalized medicine, specializing in areas related to companion diagnostics, the oncology diagnostics pilot, pharmacogenomics, next-generation sequencing, and genetic database recognition for regulatory purposes. She received her bachelor's degree from Yale University and her master's degree from University of Washington's Institute for Public Health Genetics.
Tuesday, December 5, 2023
1:00 PM – 2:00 PM ET